Effect of HIV-2 Infection on HIV-1 Disease Progression

被引：0
|
作者：
de Silva, Thushan [1 ]
Leligdowicz, Aleksandra [1 ]
Rowland-Jones, Sarah [1 ]
机构：
[1] Weatherall Inst Mol Med, Oxford, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 20期
基金：
英国医学研究理事会;
关键词：
CYTOTOXIC T-CELLS; RESPONSES; VIREMIA;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1961 / 1962
页数：2
相关论文
共 50 条
  • [21] Seronegative HIV-1 infection: a review of the literature
    Spivak, Adam M.
    Sydnor, Emily R. M.
    Blankson, Joel N.
    Gallant, Joel E.
    AIDS, 2010, 24 (10) : 1407 - 1414
  • [22] Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
    Stamatatos, Leonidas
    Morris, Lynn
    Burton, Dennis R.
    Mascola, John R.
    NATURE MEDICINE, 2009, 15 (08) : 866 - 870
  • [23] Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection
    Ndhlovu, Zaza M.
    Kazer, Samuel W.
    Nkosi, Thandeka
    Ogunshola, Funsho
    Muema, Daniel M.
    Anmole, Gursev
    Swann, Shayda A.
    Moodley, Amber
    Dong, Krista
    Reddy, Tarylee
    Brockman, Mark A.
    Shalek, Alex K.
    Ndung'u, Thumbi
    Walker, Bruce D.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (493)
  • [24] Specific Anti-gp41 Antibodies Predict HIV-1 Disease Progression
    Vieillard, Vincent
    Crouzet, Joel
    Boufassa, Faroudy
    Sennepin, Alexis
    Fang, Raphael Ho Tsong
    Debre, Patrice
    Meyer, Laurence
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (03) : 403 - 405
  • [25] HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection
    Vanderveen, Laurie A.
    Selzer, Lisa
    Moldt, Brian
    Parvangada, Aiyappa
    Li, Jiani
    Ananworanich, Jintanat
    Crowell, Trevor A.
    Eron, Joseph J.
    Daar, Eric S.
    Haubrich, Richard
    Geleziunas, Romas
    Cyktor, Joshua
    Mellors, John W.
    Callebaut, Christian
    AIDS, 2024, 38 (04) : 607 - 610
  • [26] Dynamics of the blood plasma proteome during hyperacute HIV-1 infection
    Nazziwa, Jamirah
    Freyhult, Eva
    Hong, Mun-Gwan
    Johansson, Emil
    Arman, Filip
    Hare, Jonathan
    Gounder, Kamini
    Rezeli, Melinda
    Mohanty, Tirthankar
    Kjellstroem, Sven
    Kamali, Anatoli
    Karita, Etienne
    Kilembe, William
    Price, Matt A.
    Kaleebu, Pontiano
    Allen, Susan
    Hunter, Eric
    Ndung'u, Thumbi
    Gilmour, Jill
    Rowland-Jones, Sarah L.
    Sanders, Eduard
    Hassan, Amin S.
    Esbjornsson, Joakim
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [27] The utility of nonhuman primate models for understanding acute HIV-1 infection
    Parsons, Matthew S.
    Bolton, Diane L.
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (03) : 218 - 227
  • [28] Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles
    Hamimi, Chiraz
    David, Annie
    Versmisse, Pierre
    Weiss, Laurence
    Bruel, Timothee
    Zucman, David
    Appay, Victor
    Moris, Arnaud
    Ungeheuer, Marie-Noelle
    Lascoux-Combe, Caroline
    Barre-Sinoussi, Franocise
    Muller-Trutwin, Michaela
    Boufassa, Faroudy
    Lambotte, Olivier
    Pancino, Gianfranco
    Saez-Cirion, Asier
    PLOS ONE, 2016, 11 (08):
  • [29] HIV-Selectest Enzyme Immunoassay and Rapid Test: Ability To Detect Seroconversion following HIV-1 Infection
    Khurana, Surender
    Norris, Philip J.
    Busch, Michael P.
    Haynes, Barton F.
    Park, Susan
    Sasono, Pretty
    Mlisana, Koleka
    Salim, Abdool Karim
    Hecht, Frederick M.
    Mulenga, Joseph
    Chomba, Elwyn
    Hunter, Eric
    Allen, Susan
    Nemo, George
    Rodriguez-Chavez, Isaac R.
    Margolick, Joseph B.
    Golding, Hana
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (01) : 281 - 285
  • [30] Advances in dendritic cell immunotherapies for HIV-1 infection
    Miller, Elizabeth
    Bhardwaj, Nina
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (11) : 1545 - 1549
12345